Skip to main content
Clinical Trials/IRCT20230607058407N1
IRCT20230607058407N1CompletedPhase 3

Evaliuation of the effect of Melatonin and Agomelatin on sleep problem in children and adolescent with Autism spactrum disorder

Shahid Beheshti University of Medical Sciences0 sites80 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Completed
Enrollment
80

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
3 years to 18 years (—)
Sex
All

Inclusion Criteria

  • children and adolescents with autism spectrum disorder
  • and with sleep disorders

Exclusion Criteria

  • doubt to sleep apnea
  • resistant patiants

Investigators

Similar Trials